Authors
Krisha Patel, Shaun Khanna, Nitesh Nerlekar, Aditya Bhat
Published in
Internal medicine journal. Nov 16, 2026. Epub Nov 16, 2026.
Abstract
Atherosclerotic cardiovascular disease (ASCVD) remains the leading global cause of death, and diet represents an important modifiable target for prevention. Contemporary evidence supports a shift from nutrient-based to dietary-pattern approaches with Mediterranean, DASH and high-quality plant-based diets associated with favourable effects on cardiovascular risk factors, including lipid profiles, inflammation, blood pressure and metabolic health. Conversely, Western and ultra-processed-food patterns are associated with increased ASCVD risk, potentially mediated through dyslipidaemia, visceral adiposity, inflammation and oxidative stress. Additional dietary approaches, including the Nordic, Portfolio, low-carbohydrate and intermittent fasting diets, have demonstrated effects on selected cardiometabolic risk factors, although evidence for long-term cardiovascular outcomes remains limited. Advances in metabolomic profiling provide further insight into diet-related cardiometabolic risk and may facilitate further precision-nutrition approaches. Concurrently, glucagon-like peptide-1 receptor agonists and SGLT2 inhibitors have expanded therapeutic options for cardiovascular risk reduction. Reducing the global ASCVD burden requires integration of dietary, pharmacological, clinical and policy strategies. Nutrition should remain central to ASCVD prevention rather than a secondary adjunct.
PMID:
43037262
Bibliographic data and abstract were imported from PubMed on 16 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0